Iris Katharina Low-Friedrich
CIK: 0002138283
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTX
BioNTech SE
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Low-Friedrich Iris Katharina
Low-Friedrich Iris Katharina (SEC CIK 0002138283) files insider reports with the SEC as Director of BioNTech SE (BNTX).
Signal8 holds 1 ownership filing by Low-Friedrich Iris Katharina, a Form 3, filed on Jun 26, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Low-Friedrich Iris Katharina's filings is in MAINZ.
Other insiders filing for BioNTech SE (BNTX)
- Sahin Ugur, Chief Executive Officer
- Schaffert Susanne, Director
- Zapata Gomez Ramon, Chief Financial Officer
- Ryan James Timothy Patrick
- Poetting Sierk, Chief Operating Officer
- Jimenez Kylie, Chief People Officer